These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37418899)

  • 21. Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy.
    Kim J; Vasu VT; Mishra R; Singleton KR; Yoo M; Leach SM; Farias-Hesson E; Mason RJ; Kang J; Ramamoorthy P; Kern JA; Heasley LE; Finigan JH; Tan AC
    Bioinformatics; 2014 Sep; 30(17):2393-8. PubMed ID: 24812339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Tumor Cell Response to Synergistic Drug Combinations Using a Novel Simplified Deep Learning Model.
    Zhang H; Feng J; Zeng A; Payne P; Li F
    AMIA Annu Symp Proc; 2020; 2020():1364-1372. PubMed ID: 33936513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
    Regan-Fendt KE; Xu J; DiVincenzo M; Duggan MC; Shakya R; Na R; Carson WE; Payne PRO; Li F
    NPJ Syst Biol Appl; 2019; 5():6. PubMed ID: 30820351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients.
    He L; Tang J; Andersson EI; Timonen S; Koschmieder S; Wennerberg K; Mustjoki S; Aittokallio T
    Cancer Res; 2018 May; 78(9):2407-2418. PubMed ID: 29483097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel approach to predicting the synergy of anti-cancer drug combinations using document-based feature extraction.
    Shim Y; Lee M; Kim PJ; Kim HG
    BMC Bioinformatics; 2022 May; 23(1):163. PubMed ID: 35513784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H-RACS: a handy tool to rank anti-cancer synergistic drugs.
    Yan X; Yang Y; Chen Z; Yin Z; Deng Z; Qiu T; Tang K; Cao Z
    Aging (Albany NY); 2020 Nov; 12(21):21504-21517. PubMed ID: 33173014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer.
    Vu T; Sliwkowski MX; Claret FX
    Biochim Biophys Acta; 2014 Dec; 1846(2):353-65. PubMed ID: 25065528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predict effective drug combination by deep belief network and ontology fingerprints.
    Chen G; Tsoi A; Xu H; Zheng WJ
    J Biomed Inform; 2018 Sep; 85():149-154. PubMed ID: 30081101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?
    Pieretti JC; Pelegrino MT; Nascimento MHM; Tortella GR; Rubilar O; Seabra AB
    Biochem Pharmacol; 2020 Jun; 176():113740. PubMed ID: 31786262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning.
    Chen X; Ren B; Chen M; Wang Q; Zhang L; Yan G
    PLoS Comput Biol; 2016 Jul; 12(7):e1004975. PubMed ID: 27415801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies.
    Tortora G; Bianco R; Daniele G; Ciardiello F; McCubrey JA; Ricciardi MR; Ciuffreda L; Cognetti F; Tafuri A; Milella M
    Drug Resist Updat; 2007 Jun; 10(3):81-100. PubMed ID: 17482503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to overcome resistance to targeted protein kinase inhibitors in the treatment of cancer.
    Buschbeck M
    Drugs R D; 2006; 7(2):73-86. PubMed ID: 16542054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations.
    Sun Y; Zhang W; Chen Y; Ma Q; Wei J; Liu Q
    Oncotarget; 2016 Feb; 7(8):9404-19. PubMed ID: 26824188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction.
    Li TH; Wang CC; Zhang L; Chen X
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36418927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.
    Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M
    Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiling networks of distinct immune-cells in tumors.
    Clancy T; Hovig E
    BMC Bioinformatics; 2016 Jul; 17(1):263. PubMed ID: 27377892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting chemosensitivity using drug perturbed gene dynamics.
    Mannheimer JD; Prasad A; Gustafson DL
    BMC Bioinformatics; 2021 Jan; 22(1):15. PubMed ID: 33413081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Explainable drug sensitivity prediction through cancer pathway enrichment.
    Tang YC; Gottlieb A
    Sci Rep; 2021 Feb; 11(1):3128. PubMed ID: 33542382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NEXGB: A Network Embedding Framework for Anticancer Drug Combination Prediction.
    Meng F; Li F; Liu JX; Shang J; Liu X; Li Y
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
    Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
    Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.